Holger Lembrér

Filings at 3 companies/Chief financial officer · Enzymatica AB (publ)

5 of 7 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 7. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 7 visible filings, newest first.

Enzymatica AB (publ) Chief financial officer
110,000 SEKOpen-market buy
TradedJul 17, 2026FiledJul 20, 2026
Boule Diagnostics AB Chief financial officer
155,200 SEKOpen-market buy
TradedNov 29, 2024FiledDec 2, 2024
Oncopeptides AB Chief financial officer
7,796 SEKOpen-market buy
TradedSep 8, 2023FiledSep 8, 2023
Oncopeptides AB Chief financial officer
17,626 SEKOpen-market buy
TradedSep 8, 2023FiledSep 8, 2023
Oncopeptides AB Chief financial officer
7,808 SEKOpen-market buy
TradedSep 8, 2023FiledSep 8, 2023